International Journal of Clinical Research
International Journal of Clinical Research. 2026; 10: (7) ; 10.12208/j.ijcr.20260351 .
总浏览量: 260
安康市中医医院 陕西安康
*通讯作者: 米盼盼,单位:安康市中医医院 陕西安康; ;
目的 探析参芪地黄汤加减与西医常规疗法联合治疗III期糖尿病肾病气阴两虚证的效果。方法 自2024年7月起,本院开始收集诊治III期糖尿病肾病气阴两虚证的病例资料,至2025年7月止共纳入76例,通过抽单双号法进行平均分组。一组38例采取西医常规疗法治疗设为参照组;一组38例采取参芪地黄汤加减联合西医常规疗法治疗设为实验组。对比两组血糖水平、肾功能、中医证候积分等情况。结果 实验组空腹血糖、餐后2h血糖以及糖化血红蛋白水平较参照组明显偏低(P<0.05)。实验组肾功能指标水平较参照组明显偏低(P<0.05)。实验组各项中医证候积分较参照组明显偏低(P<0.05)。结论 参芪地黄汤加减与西医常规疗法联合治疗III期糖尿病肾病气阴两虚证患者,可有效控制血糖水平,明显提升肾功能,改善中医证候效果更佳,应进一步推广。
Objective To explore the effect of Shenqi Dihuang Decoction and conventional western medicine in the treatment of stage III diabetes nephropathy with deficiency of both qi and yin. Methods From July 2024, our hospital began to collect the case data of the diagnosis and treatment of qi yin deficiency syndrome of stage III diabetes nephropathy. By July 2025, 76 cases were included, and were divided into average groups by the method of drawing single and double numbers. A group of 38 cases were treated with conventional Western medicine therapy and set as the reference group; A group of 38 cases were treated with modified Shenqi Dihuang Decoction combined with conventional Western medicine therapy as the experimental group. Compare the blood glucose levels, renal function, and traditional Chinese medicine syndrome scores between two groups. Results The fasting blood glucose, 2-hour postprandial blood glucose, and glycated hemoglobin levels in the experimental group were significantly lower than those in the reference group (P<0.05). The levels of renal function indicators in the experimental group were significantly lower than those in the reference group(P<0.05). The scores of various TCM syndromes in the experimental group were significantly lower than those in the reference group (P<0.05). Conclusion The combination of Shenqi Dihuang Decoction and conventional western medicine therapy can effectively control blood sugar level, significantly improve renal function and improve TCM syndromes in patients with stage III diabetes nephropathy with qi yin deficiency syndrome, which should be further promoted.
[1] 吕翠岩.参芪地黄汤化裁方对Ⅲ期糖尿病肾病尿蛋白及临床进展的影响[J].吉林中医药,2020,40(4):480-484.
[2] 刘怀智.参麦地黄汤联合常规治疗对气阴两虚证早期糖尿病肾病患者的临床疗效[J].中成药,2021,43(7):1759-1763.
[3] 符杨浠.参芪地黄汤加减治疗气阴两虚血瘀证糖尿病肾病Ⅳ期临床研究[J].中华中医药学刊,2019,37(12):3026-3029.
[4] 雷光锋.参麦地黄汤加减联合常规治疗对气阴两虚证早期糖尿病肾病患者的临床观察[J].贵州医药,2022,46(9): 1457-1458.
[5] 钱冬梅.参芪地黄汤加减治疗糖尿病气阴两虚证疗效及对患者炎症指标与免疫功能的影响[J].陕西中医,2022, 43(4):469-471.
[6] 马影.参芪地黄汤加味联合氯沙坦治疗气阴两虚型糖尿病.肾病临床研究[J].新中医,2020,52(6):11-13
[7] 陈小娟.气阴两虚型糖尿病肾病采用参芪地黄汤加减治疗的效果分析[J].山西医药杂志,2022,51(12):1347-1351.
[8] 郑丽.参芪地黄汤加减治疗糖尿病肾病的效果[J].中国民康医学,2020,32(3):105-107.